Sofinnova-Investments
AI_NATIVE detailed information: This accession holds the following tickers:[ "AKRO", "AXSM", "EWTX", "INSM", "JAZZ", "ACAD", "PTCT", "ALNY", "ANAB", "AVBP", "RCUS", "GPCR", "IMTX", "SVRA", "RAPP", "PHVS", "REPL", "SNDX", "GILD", "BIOA", "BOLT", "ESTA", "SRRK", "ISRG", "INBX", null, "NXTC", "MDT", "IDYA", "INCY", "SYK", "RNA", null, "PRAX", "RYTM", "SLNO", "SUPN", "QURE", "COGT", "DYN", "SRPT", "PEN", "NTRA", "ROIV", "ERAS", "ELVN", "IKNA", "IMNM", "INZY", "KURA", "VIR", "YMAB", "VERA", "BPMC", "BMY", "BBIO", "DHR", "DXCM", "IRON", "QQQ", "IWM", "LLY" ]
Filing Details
13F-HR • 2025-03-31
Filing Details
13F-HR • 2025-03-31- Report Date
- 2025-03-31
- Filing Date
- 2025-05-15
- Total Holdings
- 62
- Total Value
- 1486841997
- Accession Number
- 0001104659-25-049266
- Form Type
- 13F-HR
- Manager Name
- Sofinnova-Investments
Data Enrichment
97% identified60 identified2 unidentified
Holdings
62 positions • $1.5B total value
Manager:
Search and click to pin securities to the top
Page 3 of 4
Shares:157.6K
Value:$6.0M
% of Portfolio:0.4% ($6.0M/$1.5B)
Shares:28.7K
Value:$1.2M
% of Portfolio:0.1% ($1.2M/$1.5B)
59267L107
Shares:36.8K
Value:$1.0M
% of Portfolio:0.1% ($1.0M/$1.5B)
Shares:33.5K
Value:$660.2K
% of Portfolio:0.0% ($660.2K/$1.5B)
Shares:35.0K
Value:$605.0K
% of Portfolio:0.0% ($605.0K/$1.5B)
Instrument | Shares | Other Manager | Value | % of Portfolio | ||
|---|---|---|---|---|---|---|
| 500.0K | QoQ NEW(+500.0K) YoY NEW(+500.0K) | All Managers (Combined) | $8.3M | 0.6% ($8.3M/$1.5B) | QoQ NEW(+$8.3M) YoY NEW(+$8.3M) | |
| 1.0M | QoQ NEW(+1.0M) YoY NEW(+1.0M) | All Managers (Combined) | $8.1M | 0.5% ($8.1M/$1.5B) | QoQ NEW(+$8.1M) YoY NEW(+$8.1M) | |
| 716.9K | All Managers (Combined) | $7.5M | 0.5% ($7.5M/$1.5B) | |||
| 320.4K | YoY NEW(+320.4K) | All Managers (Combined) | $7.0M | 0.5% ($7.0M/$1.5B) | YoY NEW(+$7.0M) | |
Immatics N.V.(IMTXcusipN44445109) | 1.6M | All Managers (Combined) | $7.0M | 0.5% ($7.0M/$1.5B) | ||
| 157.6K | QoQ NEW(+157.6K) YoY NEW(+157.6K) | All Managers (Combined) | $6.0M | 0.4% ($6.0M/$1.5B) | QoQ NEW(+$6.0M) YoY NEW(+$6.0M) | |
| 12.0K | All Managers (Combined) | $5.9M | 0.4% ($5.9M/$1.5B) | |||
uniQure N.V.(QUREcusipN90064101) | 545.8K | QoQ NEW(+545.8K) YoY NEW(+545.8K) | All Managers (Combined) | $5.8M | 0.4% ($5.8M/$1.5B) | QoQ NEW(+$5.8M) YoY NEW(+$5.8M) |
Immunome Inc.(IMNMcusip45257U108) | 788.7K | All Managers (Combined) | $5.3M | 0.4% ($5.3M/$1.5B) | ||
| 791.7K | QoQ NEW(+791.7K) | All Managers (Combined) | $5.2M | 0.4% ($5.2M/$1.5B) | QoQ NEW(+$5.2M) | |
| 4.3M | All Managers (Combined) | $3.9M | 0.3% ($3.9M/$1.5B) | |||
| 116.1K | QoQ NEW(+116.1K) YoY NEW(+116.1K) | All Managers (Combined) | $3.7M | 0.3% ($3.7M/$1.5B) | QoQ NEW(+$3.7M) YoY NEW(+$3.7M) | |
Erasca, Inc.(ERAScusip29479A108) | 1.9M | YoY NEW(+1.9M) | All Managers (Combined) | $2.6M | 0.2% ($2.6M/$1.5B) | YoY NEW(+$2.6M) |
NextCure, Inc.(NXTCcusip65343E108) | 2.7M | All Managers (Combined) | $1.3M | 0.1% ($1.3M/$1.5B) | ||
| 28.7K | All Managers (Combined) | $1.2M | 0.1% ($1.2M/$1.5B) | |||
| 2.8M | All Managers (Combined) | $1.1M | 0.1% ($1.1M/$1.5B) | |||
(cusip59267L107)✕ | 36.8K | QoQ NEW(+36.8K) YoY NEW(+36.8K) | All Managers (Combined) | $1.0M | 0.1% ($1.0M/$1.5B) | QoQ NEW(+$1.0M) YoY NEW(+$1.0M) |
| 33.5K | QoQ -1.40% (-478)YoY NEW(+33.5K) | All Managers (Combined) | $660.2K | 0.0% ($660.2K/$1.5B) | YoY NEW(+$660.2K) | |
| 35.0K | All Managers (Combined) | $605.0K | 0.0% ($605.0K/$1.5B) | |||
| 83.0K | YoY NEW(+83.0K) | All Managers (Combined) | $537.9K | 0.0% ($537.9K/$1.5B) | YoY NEW(+$537.9K) |